Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Diagnostic
  • 1.3.3 Therapeutic
• 1.4 Market Segment by Application
  • 1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Share by Application (2019-2025)
  • 1.4.2 Oncology
  • 1.4.3 Thyroid
  • 1.4.4 Cardiology
  • 1.4.5 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size
  • 2.1.1 Global Nuclear Medicine/Radiopharmaceutic Revenue 2014-2025
  • 2.1.2 Global Nuclear Medicine/Radiopharmaceutic Sales 2014-2025
• 2.2 Nuclear Medicine/Radiopharmaceutic Growth Rate by Regions
  • 2.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Regions 2014-2019
  • 2.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers
  • 3.1.1 Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers 2014-2019
  • 3.1.2 Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2014-2019)
  • 3.2.2 Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Nuclear Medicine/Radiopharmaceutic Market Concentration Ratio (CR5 and HHI)
• 3.3 Nuclear Medicine/Radiopharmaceutic Price by Manufacturers
• 3.4 Key Manufacturers Nuclear Medicine/Radiopharmaceutic Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
• 3.6 Key Manufacturers Nuclear Medicine/Radiopharmaceutic Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Diagnostic Sales and Revenue (2014-2019)
  • 4.1.2 Therapeutic Sales and Revenue (2014-2019)
• 4.2 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type
• 4.3 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type
• 4.4 Nuclear Medicine/Radiopharmaceutic Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Nuclear Medicine/Radiopharmaceutic Sales by Application

6 United States

• 6.1 United States Nuclear Medicine/Radiopharmaceutic Breakdown Data by Company
• 6.2 United States Nuclear Medicine/Radiopharmaceutic Breakdown Data by Type
• 6.3 United States Nuclear Medicine/Radiopharmaceutic Breakdown Data by Application

7 European Union

• 7.1 European Union Nuclear Medicine/Radiopharmaceutic Breakdown Data by Company
• 7.2 European Union Nuclear Medicine/Radiopharmaceutic Breakdown Data by Type
• 7.3 European Union Nuclear Medicine/Radiopharmaceutic Breakdown Data by Application

8 China

• 8.1 China Nuclear Medicine/Radiopharmaceutic Breakdown Data by Company
• 8.2 China Nuclear Medicine/Radiopharmaceutic Breakdown Data by Type
• 8.3 China Nuclear Medicine/Radiopharmaceutic Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Nuclear Medicine/Radiopharmaceutic Breakdown Data by Company
• 9.2 Rest of World Nuclear Medicine/Radiopharmaceutic Breakdown Data by Type
• 9.3 Rest of World Nuclear Medicine/Radiopharmaceutic Breakdown Data by Application
• 9.4 Rest of World Nuclear Medicine/Radiopharmaceutic Breakdown Data by Countries
  • 9.4.1 Rest of World Nuclear Medicine/Radiopharmaceutic Sales by Countries
  • 9.4.2 Rest of World Nuclear Medicine/Radiopharmaceutic Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 China Isotope Radiation
  • 10.1.1 China Isotope Radiation Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
  • 10.1.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
  • 10.1.5 China Isotope Radiation Recent Development
• 10.2 Dongcheng
  • 10.2.1 Dongcheng Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
  • 10.2.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
  • 10.2.5 Dongcheng Recent Development
• 10.3 Jaco
  • 10.3.1 Jaco Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
  • 10.3.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
  • 10.3.5 Jaco Recent Development
• 10.4 Ciaeriar
  • 10.4.1 Ciaeriar Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
  • 10.4.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
  • 10.4.5 Ciaeriar Recent Development
• 10.5 Advanced Molecular-imaging Solution
  • 10.5.1 Advanced Molecular-imaging Solution Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
  • 10.5.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
  • 10.5.5 Advanced Molecular-imaging Solution Recent Development
• 10.6 Shanghai Atom Kexing
  • 10.6.1 Shanghai Atom Kexing Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
  • 10.6.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
  • 10.6.5 Shanghai Atom Kexing Recent Development
• 10.7 Cardinal Health
  • 10.7.1 Cardinal Health Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
  • 10.7.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
  • 10.7.5 Cardinal Health Recent Development
• 10.8 Mallinckrodt
  • 10.8.1 Mallinckrodt Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
  • 10.8.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
  • 10.8.5 Mallinckrodt Recent Development
• 10.9 GE Healthcare
  • 10.9.1 GE Healthcare Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
  • 10.9.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
  • 10.9.5 GE Healthcare Recent Development
• 10.10 Lantheus Medical Imaging
  • 10.10.1 Lantheus Medical Imaging Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Nuclear Medicine/Radiopharmaceutic
  • 10.10.4 Nuclear Medicine/Radiopharmaceutic Product Introduction
  • 10.10.5 Lantheus Medical Imaging Recent Development
• 10.11 Bayer Healthcare
• 10.12 Bracco Imaging
• 10.13 Eczacibasi-Monrol Nuclear Products
• 10.14 Nordion
• 10.15 Advanced Accelerator Applications
• 10.16 Iba Molecular Imaging

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Nuclear Medicine/Radiopharmaceutic Sales Channels
  • 11.2.2 Nuclear Medicine/Radiopharmaceutic Distributors
• 11.3 Nuclear Medicine/Radiopharmaceutic Customers

12 Market Forecast

• 12.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Revenue Forecast 2019-2025
• 12.2 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type
• 12.3 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application
• 12.4 Nuclear Medicine/Radiopharmaceutic Forecast by Regions
  • 12.4.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Nuclear Medicine/Radiopharmaceutic is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nuclear Medicine/Radiopharmaceutic.

This report studies the global market size of Nuclear Medicine/Radiopharmaceutic, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Nuclear Medicine/Radiopharmaceutic sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
China Isotope Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
Cardinal Health
Mallinckrodt
GE Healthcare
Lantheus Medical Imaging
Bayer Healthcare
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications
Iba Molecular Imaging

Market Segment by Product Type
Diagnostic
Therapeutic

Market Segment by Application
Oncology
Thyroid
Cardiology
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Nuclear Medicine/Radiopharmaceutic status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Nuclear Medicine/Radiopharmaceutic manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Nuclear Medicine/Radiopharmaceutic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025